ヘルスケアナノテクノロジーの世界市場レポート 2025年

ヘルスケアナノテクノロジーの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR16.8％で7,231億8,000万米ドルに成長します。予測期間の成長は、セラノスティクスの開発、遺伝子治療用ナノ粒子、生体適合性ナノ材料、ナノ対応手術器具、ナノスケール治療薬、グローバルな健康上の緊急事態への備えなどに起因すると考えられます。予測期間の主な動向には、診断用ナノデバイス、バイオセンサーと画像、ナノロボティクスとナノ手術、個別化医療、一般市民の認識と教育治療への応用が含まれます。

がん罹患率の上昇がヘルスケアナノテクノロジー市場の成長を牽引すると予測されます。ナノテクノロジーは、がん治療への有望なアプローチであり、がんを含む様々な疾患に対してより個別化された治療の可能性を提供します。がんの世界的有病率は上昇し続けています。例えば、米国がん協会は、2023年には米国で新たに195万8,310人ががんと診断され、60万9,820人ががん関連で死亡すると推定しています。これらの統計は、医療技術や早期発見法の進歩にもかかわらず、がんの予防と治療における課題が根強いことを強調しています。これらの統計は、がんに効果的に対処するための継続的な研究と効果的なヘルスケア戦略の緊急の必要性を強調しています。その結果、がん患者数の増加がヘルスケアナノテクノロジー市場の成長に拍車をかけています。

糖尿病と肥満の増加は、ヘルスケアナノテクノロジー市場の今後の成長を促進すると予想されます。糖尿病とは、血糖値が高すぎる場合に発症する状態を指し、肥満とは、BMIが30以上の状態を指します。ヘルスケアナノテクノロジーは、糖尿病と肥満を管理するための標的ドラッグデリバリーと精密医療アプローチを提供し、副作用を最小限に抑えながら治療効果を向上させます。例えば、ベルギーに本部を置く国際糖尿病連合（International Diabetes Federation）によると、2022年6月、糖尿病の有病率は世界で10.5%に増加し、そのうち半数以上（44.7%）の人々は未診断のままであると報告されています。IDFの予測によると、2045年までに7億8,300万の成人、つまり8人に1人が糖尿病を患うことになるとされています。これは、同期間の予想人口増加率（20%）の2倍以上、46%の増加を意味します。さらに、2022年3月、スイスに本拠を置く世界保健機関（WHO）によると、6億5,000万人の成人、3億4,000万人のティーンエイジャー、3,900万人の子どもが肥満になると予測されています。WHOは、2025年までに1億6,700万人の大人と子供が過体重または肥満になると予測しています。したがって、糖尿病と肥満の増加がヘルスケアナノテクノロジー市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のヘルスケアナノテクノロジー市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のヘルスケアナノテクノロジー市場の成長率分析
• 世界のヘルスケアナノテクノロジー市場の実績：規模と成長、2019～2024年
• 世界のヘルスケアナノテクノロジー市場の予測：規模と成長、2024～2029年、2034年
• 世界のヘルスケアナノテクノロジー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヘルスケアナノテクノロジー市場：疾患別、実績と予測、2019～2024年、2024～2029年、2034年
• 心血管疾患
• 腫瘍性疾患
• 神経疾患
• 整形外科疾患
• 感染症
• 世界のヘルスケアナノテクノロジー市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 有機
• 無機
• 炭素ベース
• 世界のヘルスケアナノテクノロジー市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• ドラッグデリバリー
• 生体材料
• アクティブインプラント
• 組織再生
• 世界のヘルスケアナノテクノロジー市場：心血管疾患のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ドラッグデリバリーシステム
• 画像診断
• 世界のヘルスケアナノテクノロジー市場：腫瘍性疾患のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 標的ドラッグデリバリー
• ナノ粒子ベースの治療法
• 画像診断
• 世界のヘルスケアナノテクノロジー市場：神経疾患のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ナノ粒子ベースのドラッグデリバリー
• 診断ツール
• 世界のヘルスケアナノテクノロジー市場：整形外科疾患のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 骨の再生と修復
• ドラッグデリバリーシステム
• 世界のヘルスケアナノテクノロジー市場：感染症のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗菌ナノマテリアル
• ワクチンデリバリーシステム

第7章 地域別・国別分析

• 世界のヘルスケアナノテクノロジー市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のヘルスケアナノテクノロジー市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヘルスケアナノテクノロジー市場：競合情勢
• ヘルスケアナノテクノロジー市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Sanofi SA
• Taiwan Liposome Company Ltd.
• GE Healthcare Technologies Inc.
• Mallinckrodt plc
• Leadiant Biosciences
• Luminex Corporation
• Bristol-Myers Squibb Company
• CytImmune Sciences Inc.
• Nanobiotix
• Starpharma Holdings Limited
• Copernicus Therapeutics Inc.
• NanoCarrier Co. Ltd
• LiPlasome Pharma ApS
• Nami Therapeutics Corp.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヘルスケアナノテクノロジー市場2029年-最も新しい機会を提供する国
• ヘルスケアナノテクノロジー市場2029年-最も新しい機会を提供するセグメント
• ヘルスケアナノテクノロジー市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration.

The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $344.23 billion in 2024 to $389.11 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $723.18 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and education therapeutic applications.

The rising incidence of cancer cases is anticipated to drive the growth of the healthcare nanotechnology market. Nanotechnology represents a promising approach to cancer treatment, offering the potential for more personalized therapies for various diseases, including cancer. The global prevalence of cancer continues to rise. For example, in 2023, the American Cancer Society estimated that there would be 1,958,310 new cancer diagnoses and 609,820 cancer-related deaths in the United States. These statistics underscore the persistent challenges in cancer prevention and treatment, despite advancements in medical technology and early detection methods. They highlight the urgent need for ongoing research and effective healthcare strategies to address cancer effectively. Consequently, the increasing number of cancer cases is fueling the growth of the healthcare nanotechnology market.

Growing incidences of diabetes and obesity are expected to propel the growth of the healthcare nanotechnology market going forward. Diabetes refers to a condition that develops when blood glucose levels are too high, and obesity refers to the condition of having a body mass index of 30 or more. Healthcare nanotechnology offers targeted drug delivery and precision medicine approaches to manage diabetes and obesity, improving treatment efficacy while minimizing side effects. For instance, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10. 5% worldwide, with over half (44. 7%) of people still undiagnosed. According to IDF predictions, 783 million adults, or one in eight people, will have diabetes by 2045. This would represent a 46% rise, more than double the projected population growth for the same period (20%). Furthermore, in March 2022, according to the World Health Organization, a Switzerland-based agency, 650 million adults, 340 million teenagers, and 39 million children will be obese. This quantity is still rising, and the WHO predicts that by 2025, 167 million adults and children will become overweight or obese. Therefore, growing incidences of diabetes and obesity are driving the growth of the healthcare nanotechnology market.

Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. In January 2022, NaNotics, a US-based medical company, collaborated with the Mayo Clinic to develop a cancer treatment known as NaNots. The collaboration will involve NaNotics sharing its nano-depletion platform with Mayo researchers, while the Mayo Clinic will provide its own PD-L1 antibody and a transgenic mouse model that provides human sPD-L1. Mayo Clinic is a US-based clinic dedicated to providing patient care, education, and research in various fields of medicine, including nanomedicine.

Major companies operating in the healthcare nanotechnology market are increasing their focus on introducing nanotechnology-based gel serums to gain a competitive edge in the market. Nanotechnology-based gel serums are products that incorporate nanoscale particles or delivery systems to enhance the absorption and effectiveness of active ingredients. For instance, in March 2023, ENTOD Pharmaceuticals, an India-based healthcare company, launched Eyecirque, a nanotechnology-based under-eye product, in India. Eyecirque is formulated with a cutting-edge, 100% plant-based biocellular composition, featuring vitamin A, C, and E complexes, anti-aging antioxidants, skin-brightening agents, and naturally occurring ultra-moisturizing elements that are rapidly absorbed into the skin around the eyes at a nano-molecular level. It stands as the world's first gel serum of its kind, utilizing nanotechnology to address concerns such as wrinkles, hollowness, hollow eyelids, and dark circles under the eyes.

In January 2024, GenEdit, Inc., a US-based biotechnology firm, announced a multiyear collaboration and licensing agreement with Genentech to develop innovative nanoparticles for the delivery of genetic medicines intended to treat autoimmune diseases. This partnership will utilize GenEdit's NanoGalaxy platform, emphasizing the discovery of hydrophilic nanoparticles (HNPs) for nucleic acid-based therapies. Genentech, also based in the US, is a biotechnology corporation that specializes in healthcare nanotechnology.

Major companies operating in the healthcare nanotechnology market include Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanoviricides Inc., Nanosys Inc., Nanocarrier Co. Ltd., Nanocyl SA, Nanogen Pvt. Ltd.

North America was the largest region in the healthcare nanotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the healthcare nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Nanotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare nanotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The healthcare nanotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease: Cardiovascular Diseases; Oncological Diseases; Neurological Diseases; Orthopedic Diseases; Infectious Diseases
• 2) By Type: Organic; Inorganic; Carbon-Based
• 3) By Application: Drug Delivery; Biomaterials; Active Implants; Tissue Regeneration
• Subsegments:
• 1) By Cardiovascular Diseases: Drug Delivery Systems; Diagnostic Imaging
• 2) By Oncological Diseases: Targeted Drug delivery; Nanoparticle-Based Therapies; Imaging And Diagnostics
• 3) By Neurological Diseases: Nanoparticle-Based Drug Delivery; Diagnostic Tools
• 4) By Orthopedic Diseases: Bone regeneration And Repair; Drug Delivery Systems
• 5) By Infectious Diseases: Antimicrobial Nanomaterials; Vaccine Delivery Systems
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Merck & Company Inc.; Union Chimique Belge S. A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Healthcare Nanotechnology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Healthcare Nanotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Healthcare Nanotechnology Market Growth Rate Analysis
• 5.4. Global Healthcare Nanotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Healthcare Nanotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Healthcare Nanotechnology Total Addressable Market (TAM)

6. Healthcare Nanotechnology Market Segmentation

• 6.1. Global Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Oncological Diseases
• Neurological Diseases
• Orthopedic Diseases
• Infectious Diseases
• 6.2. Global Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Organic
• Inorganic
• Carbon-Based
• 6.3. Global Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Delivery
• Biomaterials
• Active Implants
• Tissue Regeneration
• 6.4. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Cardiovascular Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Delivery Systems
• Diagnostic Imaging
• 6.5. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Oncological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Drug delivery
• Nanoparticle-Based Therapies
• Imaging And Diagnostics
• 6.6. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Neurological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoparticle-Based Drug Delivery
• Diagnostic Tools
• 6.7. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Orthopedic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone regeneration And Repair
• Drug Delivery Systems
• 6.8. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Infectious Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimicrobial Nanomaterials
• Vaccine Delivery Systems

7. Healthcare Nanotechnology Market Regional And Country Analysis

• 7.1. Global Healthcare Nanotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Healthcare Nanotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Healthcare Nanotechnology Market

• 8.1. Asia-Pacific Healthcare Nanotechnology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Healthcare Nanotechnology Market

• 9.1. China Healthcare Nanotechnology Market Overview
• 9.2. China Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Healthcare Nanotechnology Market

• 10.1. India Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Healthcare Nanotechnology Market

• 11.1. Japan Healthcare Nanotechnology Market Overview
• 11.2. Japan Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Healthcare Nanotechnology Market

• 12.1. Australia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Healthcare Nanotechnology Market

• 13.1. Indonesia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Healthcare Nanotechnology Market

• 14.1. South Korea Healthcare Nanotechnology Market Overview
• 14.2. South Korea Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Healthcare Nanotechnology Market

• 15.1. Western Europe Healthcare Nanotechnology Market Overview
• 15.2. Western Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Healthcare Nanotechnology Market

• 16.1. UK Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Healthcare Nanotechnology Market

• 17.1. Germany Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Healthcare Nanotechnology Market

• 18.1. France Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Healthcare Nanotechnology Market

• 19.1. Italy Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Healthcare Nanotechnology Market

• 20.1. Spain Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Healthcare Nanotechnology Market

• 21.1. Eastern Europe Healthcare Nanotechnology Market Overview
• 21.2. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Healthcare Nanotechnology Market

• 22.1. Russia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Healthcare Nanotechnology Market

• 23.1. North America Healthcare Nanotechnology Market Overview
• 23.2. North America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Healthcare Nanotechnology Market

• 24.1. USA Healthcare Nanotechnology Market Overview
• 24.2. USA Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Healthcare Nanotechnology Market

• 25.1. Canada Healthcare Nanotechnology Market Overview
• 25.2. Canada Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Healthcare Nanotechnology Market

• 26.1. South America Healthcare Nanotechnology Market Overview
• 26.2. South America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Healthcare Nanotechnology Market

• 27.1. Brazil Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Healthcare Nanotechnology Market

• 28.1. Middle East Healthcare Nanotechnology Market Overview
• 28.2. Middle East Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Healthcare Nanotechnology Market

• 29.1. Africa Healthcare Nanotechnology Market Overview
• 29.2. Africa Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

• 30.1. Healthcare Nanotechnology Market Competitive Landscape
• 30.2. Healthcare Nanotechnology Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

31. Healthcare Nanotechnology Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Sanofi SA
• 31.3. Taiwan Liposome Company Ltd.
• 31.4. GE Healthcare Technologies Inc.
• 31.5. Mallinckrodt plc
• 31.6. Leadiant Biosciences
• 31.7. Luminex Corporation
• 31.8. Bristol-Myers Squibb Company
• 31.9. CytImmune Sciences Inc.
• 31.10. Nanobiotix
• 31.11. Starpharma Holdings Limited
• 31.12. Copernicus Therapeutics Inc.
• 31.13. NanoCarrier Co. Ltd
• 31.14. LiPlasome Pharma ApS
• 31.15. Nami Therapeutics Corp.

32. Global Healthcare Nanotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Nanotechnology Market

34. Recent Developments In The Healthcare Nanotechnology Market

35. Healthcare Nanotechnology Market High Potential Countries, Segments and Strategies

• 35.1 Healthcare Nanotechnology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Healthcare Nanotechnology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Healthcare Nanotechnology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer